Gerald Steiner - Albemarle Corp Independent Director

ALB Stock  USD 108.38  0.60  0.55%   

Director

Mr. Gerald A. Steiner is an Independent Director of the Company. Mr. Steiner brings to the Board of Directors extensive experience, with particular focus on government affairs, global business, strategy and the agricultural industry. Chief Executive Officer and member of the board of managers of Arvegenix Inc., a renewable fuel development company, since January 2015, having previously served as Executive Vice President, Sustainability and Corporationrationrate Affairs of Monsanto Company prior to his retirement in January 2014 Mr. Steiner is a principal of Alta Grow Consulting LLC and the former Chair of the Food and Agriculture Section of the Biotechnology Industry Organization. Mr. Steiner is a past chair of the CropLife International Plant Biotechnology Strategy Council and an Executive Committee member of the Council for Biotechnology Information since 2013.
Age 60
Tenure 11 years
Address 4250 Congress Street, Charlotte, NC, United States, 28209
Phone980 299 5700
Webhttps://www.albemarle.com
Steiner is the Chairman of The Keystone Center and was a director since 2004. He is also a founder and board member of the Global Harvest Initiative, a publicprivate initiative whose mission is to sustainably double agricultural production by 2050 and cofounder of Field to Market, an agricultural sustainability organization.

Albemarle Corp Management Efficiency

The company has Return on Asset of (0.0518) % which means that on every $100 spent on assets, it lost $0.0518. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1766) %, meaning that it generated no profit with money invested by stockholders. Albemarle Corp's management efficiency ratios could be used to measure how well Albemarle Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.17, whereas Return On Tangible Assets are forecasted to decline to 0.07. At present, Albemarle Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 13.7 B, whereas Other Assets are forecasted to decline to 0.95.
Albemarle Corp has 4.31 B in debt with debt to equity (D/E) ratio of 0.5, which is OK given its current industry classification. Albemarle Corp has a current ratio of 1.7, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Albemarle to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Tracy McKibbenEcolab Inc
51
Suzanne VautrinotEcolab Inc
61
Eleuthere PontDupont De Nemours
53
Larry McVayLinde plc Ordinary
72
Melanie HealeyPPG Industries
59
Victoria ReichEcolab Inc
63
Matthew PaullAir Products and
69
Steven DavisPPG Industries
62
Michael ThamanSherwin Williams Co
57
Martin RichenhagenLinde plc Ordinary
68
Richard KramerSherwin Williams Co
57
Albert ManifoldLyondellBasell Industries NV
57
Raymond MilchovichDupont De Nemours
70
Susan KropfSherwin Williams Co
71
Michael LamachPPG Industries
57
Claire FarleyLyondellBasell Industries NV
61
Hernan BucSociedad Quimica y
71
John BrunoPPG Industries
N/A
Gonzalo YamamotoSociedad Quimica y
N/A
HingYuen HoAir Products and
61
Trinidad ReyesSociedad Quimica y
N/A
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina. Albemarle Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6000 people. Albemarle Corp (ALB) is traded on New York Stock Exchange in USA. It is located in 4250 Congress Street, Charlotte, NC, United States, 28209 and employs 9,000 people. Albemarle Corp is listed under Specialty Chemicals category by Fama And French industry classification.

Management Performance

Albemarle Corp Leadership Team

Elected by the shareholders, the Albemarle Corp's board of directors comprises two types of representatives: Albemarle Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Albemarle. The board's role is to monitor Albemarle Corp's management team and ensure that shareholders' interests are well served. Albemarle Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Albemarle Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kristin Esq, Executive President
Ahmad Khalifeh, Managing Office
Mary Brlas, Independent Director
DeeAnne Marlow, Chief Human Resource Officer, Senior Vice President
Brian Tessin, Chief Tax
Melissa Anderson, Chief Human Resource Officer, Senior Vice President
Holly Deursen, Independent Director
Cynthia Lima, Senior Officer
Alejandro Wolff, Independent Director
Eric Norris, President - Lithium Global Business Unit
Dean Seavers, Independent Director
David Ryan, Vice President - Corporate Strategy and Investor Relations
Scott Tozier, Chief Financial Officer, Executive Vice President
Diarmuid OConnell, Independent Director
Neal Sheorey, Executive CFO
Jerry Masters, Chairman of the Board, President, Chief Executive Officer
Ralf Cramer, Independent Director
Donald LaBauve, Chief Accounting Officer, Vice President, Corporate Controller
Mark Mummert, Resources Capital
Stacy Grant, Chief Counsel
Glen Merfeld, Chief Business
Netha Johnson, President - Bromine Specialties Global Business Unit
Karen Narwold, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary
Maria Brennan, Chief Officer
Meredith Bandy, Vice President - Investor Relations and Sustainability
Jacobus Fourie, Chief Officer
James OBrien, Lead Independent Director
Raphael Crawford, President - Catalysts Global Business Unit
Karen Esq, Chief VP
John III, Corporate VP
John Barichivich, Chief Accounting Officer, Vice President, Corporate Controller
Gerald Steiner, Independent Director
Patrick Thompson, Chief Officer
Glenda Minor, Independent Director
Michael Simmons, President Unit

Albemarle Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Albemarle Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Albemarle Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Albemarle Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Albemarle Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Albemarle Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Albemarle Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Albemarle Stock refer to our How to Trade Albemarle Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albemarle Corp. If investors know Albemarle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albemarle Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Dividend Share
1.605
Earnings Share
(16.76)
Revenue Per Share
55.351
Quarterly Revenue Growth
(0.41)
The market value of Albemarle Corp is measured differently than its book value, which is the value of Albemarle that is recorded on the company's balance sheet. Investors also form their own opinion of Albemarle Corp's value that differs from its market value or its book value, called intrinsic value, which is Albemarle Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albemarle Corp's market value can be influenced by many factors that don't directly affect Albemarle Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albemarle Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Albemarle Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albemarle Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.